Quality of Colonoscopy Using an endoscopic database to measure and improve quality AAPCE Memphis- November 5, 2011 David Lieberman MD Chief, Division of.

Slides:



Advertisements
Similar presentations
CT COLONOGRAPHY. CRC TRENDS  Incidence decreased by 7%  Mortality decreased by 20%  Five year survival rates increased by 12%
Advertisements

A Quality Colonoscopy: Are You Providing One?
Colorectal Cancer Screening and Surveillance FDA Advisory Committee March, 2002 David Lieberman MD Chief, Division of Gastroenterology Oregon Health Sciences.
EQUIP Training session 1
Surveillance colonoscopy after polypectomy – how frequent? Dr Chu Ming Leong Tuen Mun Hospital 1.
Screening for Colorectal Cancer Cancer Symposium: Measuring the Benefits of Screening and Treatment October 2007.
Multitarget Stool DNA Testing for Colorectal-Cancer Screening NEJM April 3, 2014 Vol 3 Imperiale, T.F. et al Presented by Melissa Spera, MD.
CCE 4: Bridging Clinical Expertise Using Predictive Computational Cancer Models CRC screening and follow-up – Semi-mechanistic model of CRC development.
DR Jameel Tariq Miro.  Lifetime incidence 5%  90% of cases occur after age 50  One-third of patients with colorectal cancer die from the disease 
Colorectal Cancer Screening & Surveillance: Anything New? Timothy C. Hoops, M.D.
CT COLONOSCOPY. Turki Alhazmi,MB.CHB, FRCPC, dABR Interventional Radiology-Body MRI Ass. Prof. Faculty of Medicine Umm Al Qura University Makkah-Saudi.
James Cross, MS Pharmaceutical Outcomes Research and Policy Program University of Washington Biobehavioral Cancer Fellows Day April 20, 2007 A risk-benefit.
Colorectal cancer: How do we approach health disparities? Marta L. Davila, MD, FASGE University of Texas MD Anderson Cancer Center.
When Is A Colonoscopy Not a Colonoscopy
Joint Hospital Surgical Grand Round 19 June 2004.
Clinical Practice Screening for Colorectal Cancer David A. Lieberman, M.D. N Engl J Med Volume 361(12): September 17, 2009.
Update on Colon Cancer Screening and Prevention
Update on Colorectal Cancer Screening Tests Source: Levin Bernard et al. Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous.
Tryggvi Björn Stefánsson Dept of Surgery Landspitali University Hospital.
Screening for Colorectal Cancer Bruce D. Greenwald, MD Associate Professor of Medicine University of Maryland School of Medicine and Greenebaum Cancer.
Bowel Screening in Scotland – Current Challenges and Possible Solutions Prof. Bob Steele Ninewells Hospital, University of Dundee.
1 The Chemoprevention of Sporadic Colorectal Cancer Issues Surrounding a Benefit/Risk Analysis in Clinical Trials Mark Avigan MD CM Medical Officer Division.
Benchmarking For Colonoscopy
Andreas Adler Charité Medical University of Berlin, Virchow Clinic Campus Central Interdisciplinary Endoscopy Unit Narrow Band versus Conventional Endoscopic.
Colonoscopy; Surveillance Indications
Slides last updated: June 2015 CRC: CLINICAL FEATURES.
An Evidence Based Approach to Colorectal Cancer Screening J. C. Ryan, M.D. Associate Professor of Medicine UCSF and SF VAMC 9/22/2014.
Unit 3 Discussion Question: Group B Could Mr. C have avoided getting colorectal cancer?
COLONOSCOPY QUALITY: FROM ASSESSMENT TO IMPLEMENTATION
Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based fecal occult blood testing: a population-based controlled trial.
80% by 2018 Forum: Increasing CRC Screening Rates 80% by 2018 Forum: Increasing CRC Screening Rates Implementing a Quality Screening Navigation Program.
Brian Cox Research Associate Professor: Cancer epidemiology and screening University of Otago Hugh Adam Cancer Epidemiology Unit Department of Preventive.
The effects of inadequate preparation quality for colonoscopy Eric Sherer and Michael Catlin August 20 th, 2010 HSR&D Work-in-Progress 1.
Robert E. Schoen, MD MPH Associate Professor of Medicine and Epidemiology Division of Gastroenterology University of Pittsburgh Organizing Colorectal Cancer.
Screening for Colorectal Cancer (CRC) Nov, 2007 A Aljebreen, FRCPC Division of Gastroenterology KKUH, Riyadh.
Colon Cancer Screening- Rationale Behind the Guidelines.
Modeling Efforts to Inform Countries’ Screening Decisions Ann Graham Zauber, Iris Vogelaar, Marjolein van Ballegooijen, Deb Schrag, Rob Boer, Dik Habbema,
Colorectal Cancer Screening Colorectal Cancer Screening VT SGNA Conference VT SGNA Conference October 24, 2015 October 24, 2015 Lynn Butterly, MD Lynn.
Sessile Serrated Adenomas: A Case Presentation Kevin Witt, PGY3 Justin Whitt, MD IU Health Ball Memorial Family Medicine Residency.
Optical Diagnosis for Colorectal Polyps? Steve Schrock, MD, FAAFP November 5, 2015.
CT Colonography vs Colonoscopy for the Detection of Advanced Neoplasia David H. Kim, M.D., Perry J. Pickhardt, M.D., Andrew J. Taylor, M.D., Winifred K.
High Quality Screening Colonoscopy Colonoscopy is a common endoscopic procedure, with more than 3 million examinations performed in the United States annually.
Colorectal Cancer Screening Implementation of a public health programme An Expert Group on Colorectal Cancer Screening Cancer Society of Finland, Finnish.
D EPARTMENT of F AMILY M EDICINE Colorectal Cancer Screening: Update on Guidelines and Projects Barcey T. Levy, PhD, MD Professor, Department of Family.
Interval Colorectal Cancer 전임의 남지혁 Comparison of the Observed Incidence of Colorectal Cancer in the National Polyp Study Cohort with That.
Once-Daily Celecoxib Effective for Preventing Sporadic Colorectal Adenomas Slideset on: Arber N, Rácz I, Spicak J, et al. Chemoprevention of colorectal.
1 Yize R. Wang, MD, PhD, John R. Cangemi, MD, Edward V. Loftus Jr, MD and Michael F. Picco, MD, PhD Am J Gastroenterol 2013;108:444–449 F1 김혁 / Prof. 김효종.
The Malignant Polyp Handout Version Hans Elzinga, MD Program Director- Advanced Procedures in Family Medicine Fellowship Salud Family Health Center-Longmont,
GASTROINTESTINAL ENDOSCOPY Volume 78, No. 3 : 2013 F1 김태영
R4 채정민 / Prof 이창균. INTRODUCTION colonoscopy is a widely used screening tool for colorectal cancer adenoma detection rate (ADR) important quality indicator.
Dana Ben-Am Center for Autoimmune Diseases Department of Medicine ‘B’ Sheba Medical Center May 2010 Screening for Colorectal Cancer.
Quality Improvement in Gastroenterology Aparajita Singh, MD, MPH Assistant Clinical Professor Division of Gastroenterology.
CLinical EValuation of the EndoRings: “The CLEVER study” Interim results of a randomized, multicenter, tandem colonoscopy study Introduction Adenomas can.
Am J Gastroenterol 2012; 107:1213– June 2012 R3. 김동희 /prof. 이창균.
High Quality Screening Colonoscopy Colonoscopy is a common endoscopic procedure, with more than 3 million examinations performed in the United States annually.
Colonoscopic Polypectomy and Long-Term Prevention of Colorectal- Cancer Deaths N ENG J MED ;8 : Ann G. Zauber, Ph.D, Sidney J. Winawer,
Clinical process indicators
Colorectal Cancer Screening Guidelines
Sessile Serrated Adenomas: An Evidence-Based Guide to Management
Jasper Vleugels PhD-student AMC
Repeat Colonoscopy Recommendations
Improving Quality Measures for Colonoscopy and CRC Prevention
Feeling Rushed? Does Late Start Time Predict Poor Quality Colonoscopy?
Sessile Serrated Adenomas: An Evidence-Based Guide to Management
Volume 154, Issue 3, Pages e18 (February 2018)
Sang Man Park, Min Kyu Jung, Seong Woo Jeon, Sung Kook Kim
Heiko Pohl, Douglas J. Robertson 
Risks of interval colorectal cancer in a FIT-based screening program
Colonoscopy in crc screening
Volume 138, Issue 6, Pages (May 2010)
Presentation transcript:

Quality of Colonoscopy Using an endoscopic database to measure and improve quality AAPCE Memphis- November 5, 2011 David Lieberman MD Chief, Division of Gastroenterology and Hepatology Oregon Health Sciences University Portland VAMC

Colorectal Cancer Screening Normal Colon AdvancedAdenoma 10-20% Lifetime Risk Genetic Environmental Lifestyle 5-6% Lifetime Risk FIT gFOBT

Early Cancer Detection Tests Requires programmatic adherence with (+) and (-) tests Programmatic performance: Unlikely to result in much cancer prevention gFOBT FIT UNKNOWN

Colorectal Cancer Screening Normal Colon AdvancedAdenoma 10-20% Lifetime Risk Genetic Environmental Lifestyle 5-6% Lifetime Risk

gFOBT FIT Genetic/Proteomics Imaging All paths lead to colonoscopy Colonoscopy

CRC Screening in USA MMWR 2010; 59:

Goals of Colonoscopy How are we doing? GoalsEndpoints Early cancer detectionMortality reduction Detection/removal of cancer precursor lesions 1.Reduce CRC incidence 2.Absence of interval cancer within 3 years

Canada - Ontario Rabenek et al; Am J Gastroenterol advance online pub. 2 March 2010; doi /ajg Regional rates of complete colonoscopy in Ontario, per 1,000 population aged 50–90 years, by year 3% For every increase in colonoscopy rate of 1% (10/1000), there is a 3% decrease in hazard of death (HR 0.97; 95% CI ) Colonoscopy per %3%

CRC Death Rates in USA Better treatment? Early detection? Reduced Incidence? MalesFemales

CRC risk reduction with colonoscopy StudyIncidence reductionMortality Reduction COLONOSCOPY Singh, % Lakoff, % Baxter, 2009;Case-Control 31% Kahi, %65% Brenner, 2011;Case-Control 77% Singh;JAMA 2006;295: Bressler; Gastroenterol 2007; 132: Lakoff; ClinGastro Hep 2008;6: Baxter;Ann Intern Med 2009; 150:1-8 Brenner Ann Intern Med 2011; 154:22-30 Atkin; The Lancet, early online publication, 28,April, 2010 Segnan; JNCI; Sept 7, 2011 Less protection or No protection in Proximal Colon

Interval Cancer: What is the risk? Cooper et al; Gastroenterol 2010: 138: S24 Singh, Am J Gastroenterol 28 Sept 2010 on line Baxter et al; Gastroenterol 2011; 140: Pabby, GIE 2005; 61: Alberts; NEJM : Robertson; Gastroenterol 2005;129:34-41 Bertagnolli; NEJM 2006;355: Arber; NEJM 2006; 355: Baron; Gastroenterol 2006; 131: Lieberman; Gastroenterol 2007; 133: After Polypectomy Incidence: % in 3-5 yrs cancers /1000 person yrs After (-) Colonoscopy 2-9% of cancers in registry (within 6-36 months)

Interval Cancer: WHY? New, fast growing lesions –Sawhney et al; Gastroenterology 2006; 131: Incomplete removal (19-27%)Incomplete removal (19-27%) –Pabby et al; Gastrointest Endosc 2005; 61: Soetikno;JAMA 2008; 299: Farrar; CGH 2006; 4:

Interval Cancer: WHY? New, fast growing lesions Incomplete removal (19-27%) Missed lesionsMissed lesions –2-12% of polyps > 1cm are missed !! –Less protection in proximal colon

Interval Cancer NCI Pooling ProjectNCI Pooling Project Robertson, Lieberman, Winawer; DDW Interval Cancers

Colonoscopy: how do we assess quality?

Quality in Medicine How do we know high quality? How do we measure it? How do we monitor it? How do we improve it?

Quality makes a difference Interval Cancers (7-36 mos) Distal (n=584)Proximal (n=676) High completion rate (>95% vs < 80%) OR = 0.73OR = 0.72 Ontario All Cancers: n = 14,064 Interval cancers: n = 1260 (9%) Baxter et al; Gastroenterology 2011: 140:65-72

Variation in Practice: Withdrawal Time and Polyp Detection Barclay R et al. NEJM 2006;355

Quality makes a difference Interval Cancers (7-36 mos) Distal (n=584)Proximal (n=676) High polypectomy rate (>25% vs <10%) (surrogate for adenoma detection rate) (NS) (significant) Ontario All Cancers: n = 14,064 Interval cancers: n = 1260 (9%) Baxter et al; Gastroenterology 2011: 140:65-72

Risk of Interval Cancer Kaminski; NEJM 2010: 362: Relationship between quality indicator (ADR) and key outcome (interval cancer)

Colonoscopy Quality: Impact on Cost Poor prep: repeat procedures Incomplete exams: repeat procedures Concern about interval cancers: Shortened intervals between exams Surveillance over-utilization Adverse events: cost of care $$$

Set Standard Evidence-based Collect Data Assess performance Improve/ refine Post-Modern Colonoscopy Quality Assessment 1.Demonstrate that indicator is linked to key outcome 2.Develop measuring tools

NationalEndoscopicDatabase

Data Collection/Transmission Central Databank Patient Privacy

Central Data Bank DATA ? ?

Levels of Quality Reporting IndicatorsReporting Indicators –Bowel Prep Quality Performance Indicators Key Outcomes

Levels of Quality Reporting Indicators:Reporting Indicators: Bowel Prep Quality Quality of Prep documented Non-rural CORIRural CORICROP- Oregon # with documented bowel prep 90,57521, % adequate95.5%96.6%94.1%

Levels of Quality Reporting Indicators Performance Indicators :Performance Indicators : Depth of insertion Cecum reachedNon-rural CORIRural CORICROP- Oregon # with documented insertion depth 90,57521, % cecal intubation90.3%91.0%87.0% photodocumentation8.5%16.8%7.8% Landmarks noted11.0%18.9%19.4%

Levels of Quality Reporting Indicators Performance Indicators :Performance Indicators : Withdrawal Time Cecum reachedNon-rural CORIRural CORICROP- Oregon # exams with no bx or polypectomy 33,9059,2541,453 % documented w/d time 54.1%53.3%55.1% Time <6min4.7%12.6%9.1%

Levels of Quality Reporting Indicators Performance Indicators PolypsNon-rural CORIRural CORICROP- Oregon #51,84112,4292,366 Polyps removed (%) % retrieved

Polyp Detection Rate PolypsNon-rural CORIRural CORICROP- Oregon # screening CSP33,9059,2541,453 Polyps detected (%) Largest >9mm Future Indicator: Recommendation of appropriate surveillance interval after polyps detected and removed

Levels of Quality Reporting Indicators Performance Indicators Key OutcomesKey Outcomes –Disease-free survival – rates of interval cancer –Harms –Quality of life

Levels of Quality Reporting Indicators Performance Indicators Key OutcomesKey Outcomes –Disease-free survival – rates of interval cancer –Harms –Quality of life

Set Standard Evidence-based Collect Data Assess performance Improve/ refine Post-Modern Colonoscopy Quality Assessment Preliminary Data from Rural Oregon: Performance meeting benchmarks